198 patients with single - or dual-chamber implantable cardioverter-defibrillator ( ICD ) implanted for primary or secondary prevention of sudden cardiac death were randomized into a group of patients followed through standard outpatient visits ( HM - ) and a group telemonitored by the HM system ( HM + ) .